{
  "title": "Paper_1095",
  "abstract": "pmc Viruses Viruses 1559 viruses viruses Viruses 1999-4915 Multidisciplinary Digital Publishing Institute  (MDPI) PMC12474464 PMC12474464.1 12474464 12474464 41012587 10.3390/v17091159 viruses-17-01159 1 Review Epitranscriptomic Regulation of Hepatitis B Virus by RNA 5-Methylcytosine: Functions, Mechanisms, and Therapeutic Potential Zhou Xuliu 1 Huang Yanling 2 Zhang Xueyan 2 Guan Wuxiang 2 Zhang Fang 3 * Hao Haojie 2 * Husain Matloob Academic Editor Ahmed Farjana Academic Editor 1 2 3 * zhangfang@hbjxlab.com haohj@wh.iov.cn 24 8 2025 9 2025 17 9 497677 1159 06 7 2025 20 8 2025 22 8 2025 24 08 2025 28 09 2025 29 09 2025 © 2025 by the authors. 2025 https://creativecommons.org/licenses/by/4.0/ Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( https://creativecommons.org/licenses/by/4.0/ Hepatitis B virus (HBV) remains a major global health challenge, with over 296 million people chronically infected worldwide. Despite the availability of antiviral therapies, a functional cure is rarely achieved, highlighting the need for novel therapeutic strategies. RNA 5-methylcytosine (m 5 5 5 5 5 5 5 6 5 5 5 hepatitis B virus (HBV) 5-methylcytosine (m 5 NSUN2 RNA modification viral replication hepatocellular carcinoma (HCC) Natural Science Foundation of Hubei Province 2024AFB1065 2025AFB976 Hubei Jiangxia Laboratory Biosafety Key R&D Project JXBS013 Hubei Province Young Science and Technology Talent Morning Light Lift Project 202415 National Key Research and Development Program 2024YFC2309400 Strategic Priority Research Program of the Chinese Academy of Sciences XDB0490000 This work was supported by the Natural Science Foundation of Hubei Province [2024AFB1065, 2025AFB976], the Hubei Jiangxia Laboratory Biosafety Key R&D Project [JXBS013], the Hubei Province Young Science and Technology Talent Morning Light Lift Project [202415], the National Key Research and Development Program [2024YFC2309400], and the Strategic Priority Research Program of the Chinese Academy of Sciences [XDB0490000]. pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes 1. Introduction Hepatitis B virus (HBV) causes chronic infections in over 290 million individuals worldwide and remains a leading cause of liver cirrhosis and hepatocellular carcinoma (HCC) [ 1 1 2 3 In recent years, post-transcriptional regulation of viral and host RNAs via epitranscriptomic modifications has emerged as a crucial layer of host–virus interaction. To date, more than 180 distinct chemical modifications have been identified on RNA [ 4 6 5 7 1 4 5 Table 1 5 6 6 7 8 9 Despite growing interest in RNA modifications during viral infections, the role of m 5 5 2. RNA m 5 m 5 38 5 39 5 40 5 2.1. m 5 Methyltransferases (writers) transfer a methyl group from S-adenosyl-L-methionine (SAM) to the C5 position of cytosine to form 5-methylcytosine [ 41 5 42 43 44 45 5 46 47 48 49 50 5 51 Figure 1 2.2. m 5 The removal of 5-methylcytosine (m 5 52 5 5 5 5 53 54 55 5 5 56 57 5 Figure 1 2.3. m 5 Reader proteins specifically recognize m 5 5 52 58 59 60 5 61 62 5 58 5 58 5 60 5 5 59 5 63 64 Figure 1 5 3. Biological Functions of m 5 The biological roles of m 5 6 5 65 3.1. m 5 m 5 66 67 5 61 68 5 6 69 5 6 70 5 71 72 Figure 2 5 73 5 74 3.2. m 5 m 5 52 54 Figure 2 5 75 5 Asp-GTC Gly-GCC 66 76 5 5 54 77 78 5 79 80 4. Detection Methods of RNA m 5 Although m 5 81 82 5 4.1. RNA Bisulfite Sequencing (RNA-BisSeq) RNA-BisSeq, originally developed for DNA methylation analysis [ 83 84 5 5 Figure 3 85 4.2. Immunoprecipitation-Based Techniques Antibody-based methods such as MeRIP-seq enrich for m 5 86 Figure 3 5 86 5 87 Figure 3 5 5 88 Figure 3 4.3. LC-MS/MS and Nanopore Sequencing LC-MS/MS (Liquid Chromatography–Tandem Mass Spectrometry) enables quantitative detection of global m 5 Figure 3 85 89 Figure 3 5. Molecular Mechanisms of HBV-Related HCC Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer, with chronic HBV infection as a principal etiological factor [ 90 74 91 8 9 92 5.1. HBV Replication Cycle HBV enters host hepatocytes via sodium taurocholate co-transporting polypeptide (NTCP)-mediated endocytosis [ 93 94 95 Figure 4 5.2. HBV DNA Integration into the Host Genome Integration of HBV DNA into the host genome is a hallmark of chronic infection and is detected in up to 80–90% of HBV-related HCC cases [ 95 96 97 98 99 Figure 4 5.3. HBV Genomic Mutations HBV is a DNA virus with a high mutation rate due to the lack of proofreading activity by its reverse transcriptase. The viral genome includes four open reading frames (ORFs)—S, P, C, and X [ 100 101 102 103 104 105 106 Figure 4 5.4. Abnormal Expression of the HBx Gene and Its Encoded Protein The HBx gene, one of four overlapping ORFs in the HBV genome, encodes the multifunctional HBx protein, a key regulator in HBV pathogenesis [ 107 108 107 109 110 111 112 113 114 115 105 Figure 4 6. The Role of m 5 Epitranscriptomic modifications regulate critical phases of viral infection. In HBV, the pgRNA functions dually as the reverse transcription template and as the bicistronic mRNA encoding core and polymerase proteins. While m 6 116 117 118 5 6.1. m 5 m 5 5 119 119 119 5 120 5 5 Figure 5 6.2. m 5 Reverse transcription of pgRNA into HBV DNA is initiated at the ε stem-loop structure located at the 5′ end of the pgRNA. This structure is required for viral polymerase recognition and serves as the initiation site for (-)-strand DNA synthesis. Several cytosines in ε are subject to m 5 5 5 120 5 6 120 Figure 5 6.3. m 5 Unlike many DNA viruses, HBV primarily triggers host innate immunity through RNA-sensing mechanisms rather than DNA-sensing pathways. This is largely because hepatocytes express low levels of key DNA-sensing factors, such as the stimulator of interferon genes (STING), rendering RNA pattern recognition receptors—particularly retinoic acid-inducible gene I (RIG-I)—the principal sensors of HBV infection [ 121 5 122 5 5 5 5 5 5 5 5 5 Figure 5 7. m 5 m 5 5 123 124 5 125 5 126 5 5 127 Beyond cancer, m 5 128 5 5 5 129 5 130 5 Currently, the role of RNA m 5 131 132 5 8. Crosstalk Between m 5 RNA modifications often coexist on the same transcript and cooperate to form an intricate “epitranscriptomic code.” In HBV, the most abundant internal modification, m 6 6 133 6 In the case of HBV, it remains unclear whether m 6 5 5 6 5 134 135 9. Comparative Insights: m 5 m 5 5 11 5 136 5 137 5 5 138 5 139 5 140 141 5 5 5 Table 2 10. Clinical and Therapeutic Perspectives 10.1. Genotype- and Host-Dependent Variation in m 5 HBV comprises at least ten major genotypes (A–J), which differ in their geographic prevalence, disease progression, and treatment response. It remains to be determined whether differential HBV genotypes harbor distinct m 5 5 5 10.2. m 5 Dysregulation of the m 5 144 5 126 140 5 10.3. Targeting the m 5 Given the dual roles of m 5 5 5 5 5 11. Conclusions and Outlook RNA m 5 5 5 5 5 Despite these advances, several challenges and opportunities remain. First, the interplay among m 5 6 5 5 In summary, m 5 5 5 Disclaimer/Publisher’s Note: Author Contributions Conceptualization, X.Z. (Xuliu Zhou), W.G., F.Z. and H.H.; writing and editing, X.Z. (Xuliu Zhou), Y.H., X.Z. (Xueyan Zhang), W.G., F.Z. and H.H.; funding acquisition, W.G., F.Z. and H.H. All authors have read and agreed to the published version of the manuscript. Institutional Review Board Statement Not applicable. Informed Consent Statement Not applicable. Data Availability Statement No new data were created or analyzed in this study. Data sharing is not applicable to this article. Conflicts of Interest The authors declare no conflicts of interest. References 1. Yardeni D. Ghany M.G. Review article: Hepatitis B-current and emerging therapies Aliment. Pharmacol. Ther. 2022 55 805 819 10.1111/apt.16828 35224760 2. Li H. Yan L. Shi Y. Lv D. Shang J. Bai L. Tang H. Hepatitis B Virus Infection: Overview Adv. Exp. Med. Biol. 2020 1179 1 16 10.1007/978-981-13-9151-4_1 31741331 3. Hu J. Protzer U. Siddiqui A. Revisiting Hepatitis B Virus: Challenges of Curative Therapies J. Virol. 2019 93 e01032-19 10.1128/JVI.01032-19 31375584 PMC6798116 4. Boccaletto P. Stefaniak F. Ray A. Cappannini A. Mukherjee S. Purta E. Kurkowska M. Shirvanizadeh N. Destefanis E. Groza P. MODOMICS: A database of RNA modification pathways Nucleic Acids Res. 2022 50 D231 D235 10.1093/nar/gkab1083 34893873 PMC8728126 5. Roundtree I.A. Evans M.E. Pan T. He C. Dynamic RNA Modifications in Gene Expression Regulation Cell 2017 169 1187 1200 10.1016/j.cell.2017.05.045 28622506 PMC5657247 6. Chen X. Li A. Sun B.F. Yang Y. Han Y.N. Yuan X. Chen R.X. Wei W.S. Liu Y. Gao C.C. 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs Nat. Cell Biol. 2019 21 978 990 10.1038/s41556-019-0361-y 31358969 7. Chen Z. Huang L. Wang K. Zhang L. Zhong X. Yan Z. Liu B. Zhu P. rtcisE2F promotes the self-renewal and metastasis of liver tumor-initiating cells via N 6 Sci. China Life Sci. 2022 65 1840 1854 10.1007/s11427-021-2038-5 35266112 8. Zheng Z.H. Zhang G.L. Jiang R.F. Hong Y.Q. Zhang Q.Y. He J.P. Liu X.R. Yang Z.S. Yang L. Jiang X. METTL3 is essential for normal progesterone signaling during embryo implantation via m 6 Proc. Natl. Acad. Sci. USA 2023 120 e2214684120 10.1073/pnas.2214684120 36693099 PMC9945998 9. Qiao Y. Sun Q. Chen X. He L. Wang D. Su R. Xue Y. Sun H. Wang H. Nuclear m6A reader YTHDC1 promotes muscle stem cell activation/proliferation by regulating mRNA splicing and nuclear export eLife 2023 12 e82703 10.7554/eLife.82703 36892464 PMC10089659 10. Li J. Zhang L. The emerging role of m 5 Virology 2025 610 110606 10.1016/j.virol.2025.110606 40543181 11. Liu L. Chen Z. Zhang K. Hao H. Ma L. Liu H. Yu B. Ding S. Zhang X. Zhu M. NSUN2 mediates distinct pathways to regulate enterovirus 71 replication Virol. Sin. 2024 39 574 586 10.1016/j.virs.2024.05.002 38768712 PMC11401462 12. Zhang Y. Zhang L.S. Dai Q. Chen P. Lu M. Kairis E.L. Murugaiah V. Xu J. Shukla R.K. Liang X. 5-methylcytosine (m 5 Proc. Natl. Acad. Sci. USA 2022 119 e2123338119 10.1073/pnas.2123338119 36240321 PMC9586267 13. Ye L. Yao X. Xu B. Chen W. Lou H. Tong X. Fang S. Zou R. Hu Y. Wang Z. RNA epigenetic modifications in ovarian cancer: The changes, chances, and challenges Wiley Interdiscip. Rev. RNA 2023 14 e1784 10.1002/wrna.1784 36811232 14. Winans S. Beemon K. m 5 Cell Host Microbe 2019 26 154 155 10.1016/j.chom.2019.07.019 31415745 15. Zhang X. Peng Q. Wang L. N 6 Cell. Mol. Biol. Lett. 2023 28 78 10.1186/s11658-023-00490-5 37828480 PMC10571408 16. Zhu M. Huang F. Sun H. Liu K. Chen Z. Yu B. Hao H. Liu H. Ding S. Zhang X. Characterization of ACTN4 as a novel antiviral target against SARS-CoV-2 Signal Transduct. Target. Ther. 2024 9 243 10.1038/s41392-024-01956-4 39289355 PMC11408661 17. Meyer K.D. Jaffrey S.R. The dynamic epitranscriptome: N6-methyladenosine and gene expression control Nat. Rev. Mol. Cell Biol. 2014 15 313 326 10.1038/nrm3785 24713629 PMC4393108 18. Meng Y. Shu Z. Wang X. Hong L. Wang B. Jiang J. He K. Cao Q. Shi F. Wang H. Hepatitis B Virus-Mediated m6A Demethylation Increases Hepatocellular Carcinoma Stemness and Immune Escape Mol. Cancer Res. 2024 22 642 655 10.1158/1541-7786.MCR-23-0720 38546386 PMC11217737 19. Li S. Mason C.E. The pivotal regulatory landscape of RNA modifications Annu. Rev. Genom. Hum. Genet. 2014 15 127 150 10.1146/annurev-genom-090413-025405 24898039 20. Zhang X. Qin S. Huang F. Liu H. Wang J. Chen Z. Hao H. Ding S. Liu L. Yu B. N4-acetylcytidine coordinates with NP1 and CPSF5 to facilitate alternative RNA processing during the replication of minute virus of canines Nucleic Acids Res. 2025 53 gkaf229 10.1093/nar/gkaf229 40167508 PMC11959542 21. Schiffers S. Oberdoerffer S. ac4C: A fragile modification with stabilizing functions in RNA metabolism RNA 2024 30 583 594 10.1261/rna.079948.124 38531654 PMC11019744 22. Hao H. Liu W. Miao Y. Ma L. Yu B. Liu L. Yang C. Zhang K. Chen Z. Yang J. N4-acetylcytidine regulates the replication and pathogenicity of enterovirus 71 Nucleic Acids Res. 2022 50 9339 9354 10.1093/nar/gkac675 35971620 PMC9458434 23. Zheng Q. Gan H. Yang F. Yao Y. Hao F. Hong L. Jin L. Cytoplasmic m 1 1 Cell Discov. 2020 6 12 10.1038/s41421-020-0144-4 32194978 PMC7062805 24. Yan Q. Zhou J. Wang Z. Ding X. Ma X. Li W. Jia X. Gao S.J. Lu C. NAT10-dependent N 4 Nat. Commun. 2023 14 6327 10.1038/s41467-023-42135-3 37816771 PMC10564894 25. Tsai K. Jaguva Vasudevan A.A. Martinez Campos C. Emery A. Swanstrom R. Cullen B.R. Acetylation of Cytidine Residues Boosts HIV-1 Gene Expression by Increasing Viral RNA Stability Cell Host Microbe 2020 28 306 312.e306 10.1016/j.chom.2020.05.011 32533923 PMC7429276 26. Pereira-Montecinos C. Valiente-Echeverría F. Soto-Rifo R. Epitranscriptomic regulation of viral replication Biochim. Biophys. Acta Gene Regul. Mech. 2017 1860 460 471 10.1016/j.bbagrm.2017.02.002 28219769 27. Levi O. Arava Y.S. Pseudouridine-mediated translation control of mRNA by methionine aminoacyl tRNA synthetase Nucleic Acids Res. 2021 49 432 443 10.1093/nar/gkaa1178 33305314 PMC7797078 28. Carlile T.M. Martinez N.M. Schaening C. Su A. Bell T.A. Zinshteyn B. Gilbert W.V. mRNA structure determines modification by pseudouridine synthase 1 Nat. Chem. Biol. 2019 15 966 974 10.1038/s41589-019-0353-z 31477916 PMC6764900 29. Martinez N.M. Su A. Burns M.C. Nussbacher J.K. Schaening C. Sathe S. Yeo G.W. Gilbert W.V. Pseudouridine synthases modify human pre-mRNA co-transcriptionally and affect pre-mRNA processing Mol. Cell 2022 82 645 659.e649 10.1016/j.molcel.2021.12.023 35051350 PMC8859966 30. Li S. Feng T. Liu Y. Yang Q. Song A. Wang S. Xie J. Zhang J. Yuan B. Sun Z. m 1 Int. J. Oral Sci. 2024 16 36 10.1038/s41368-024-00304-0 38730256 PMC11087574 31. Filipowicz W. Functions of the 5′-terminal m 7 FEBS Lett. 1978 96 1 11 10.1016/0014-5793(78)81049-7 729775 32. Kiriakidou M. Tan G.S. Lamprinaki S. De Planell-Saguer M. Nelson P.T. Mourelatos Z. An mRNA m7G cap binding-like motif within human Ago2 represses translation Cell 2007 129 1141 1151 10.1016/j.cell.2007.05.016 17524464 33. Ma J. Han H. Huang Y. Yang C. Zheng S. Cai T. Bi J. Huang X. Liu R. Huang L. METTL1/WDR4-mediated m 7 7 Mol. Ther. 2021 29 3422 3435 10.1016/j.ymthe.2021.08.005 34371184 PMC8636169 34. Létoquart J. Huvelle E. Wacheul L. Bourgeois G. Zorbas C. Graille M. Heurgué-Hamard V. Lafontaine D.L. Structural and functional studies of Bud23-Trm112 reveal 18S rRNA N 7 Proc. Natl. Acad. Sci. USA 2014 111 E5518 E5526 10.1073/pnas.1413089111 25489090 PMC4280632 35. Werner M. Purta E. Kaminska K.H. Cymerman I.A. Campbell D.A. Mittra B. Zamudio J.R. Sturm N.R. Jaworski J. Bujnicki J.M. 2′-O-ribose methylation of cap2 in human: Function and evolution in a horizontally mobile family Nucleic Acids Res. 2011 39 4756 4768 10.1093/nar/gkr038 21310715 PMC3113572 36. Belanger F. Stepinski J. Darzynkiewicz E. Pelletier J. Characterization of hMTr1, a human Cap1 2′-O-ribose methyltransferase J. Biol. Chem. 2010 285 33037 33044 10.1074/jbc.M110.155283 20713356 PMC2963352 37. Drazkowska K. Tomecki R. Warminski M. Baran N. Cysewski D. Depaix A. Kasprzyk R. Kowalska J. Jemielity J. Sikorski P.J. 2′-O-Methylation of the second transcribed nucleotide within the mRNA 5′ cap impacts the protein production level in a cell-specific manner and contributes to RNA immune evasion Nucleic Acids Res. 2022 50 9051 9071 10.1093/nar/gkac722 36018811 PMC9458431 38. Lu Y. Yang L. Feng Q. Liu Y. Sun X. Liu D. Qiao L. Liu Z. RNA 5-Methylcytosine Modification: Regulatory Molecules, Biological Functions, and Human Diseases Genom. Proteom. Bioinform. 2024 22 qzae063 10.1093/gpbjnl/qzae063 PMC11634542 39340806 39. Bourgeois G. Ney M. Gaspar I. Aigueperse C. Schaefer M. Kellner S. Helm M. Motorin Y. Eukaryotic rRNA Modification by Yeast 5-Methylcytosine-Methyltransferases and Human Proliferation-Associated Antigen p120 PLoS ONE 2015 10 e0133321 10.1371/journal.pone.0133321 26196125 PMC4510066 40. Xu Y. Qi S. Zhang G. Liu D. Xu D. Qin T. Cheng Q. Kang H. Hu B. Huang Z. One-pot ligation of multiple mRNA fragments on dsDNA splint advancing regional modification and translation Nucleic Acids Res. 2025 53 gkae1280 10.1093/nar/gkae1280 39778864 PMC11707544 41. Trixl L. Lusser A. The dynamic RNA modification 5-methylcytosine and its emerging role as an epitranscriptomic mark Wiley Interdiscip. reviews. RNA 2019 10 e1510 10.1002/wrna.1510 30311405 PMC6492194 42. Goll M.G. Kirpekar F. Maggert K.A. Yoder J.A. Hsieh C.L. Zhang X. Golic K.G. Jacobsen S.E. Bestor T.H. Methylation of tRNA Asp by the DNA methyltransferase homolog Dnmt2 Science 2006 311 395 398 10.1126/science.1120976 16424344 43. Chen H. Yang H. Zhu X. Yadav T. Ouyang J. Truesdell S.S. Tan J. Wang Y. Duan M. Wei L. m 5 Nat. Commun. 2020 11 2834 10.1038/s41467-020-16722-7 32503981 PMC7275041 44. Xue S. Xu H. Sun Z. Shen H. Chen S. Ouyang J. Zhou Q. Hu X. Cui H. Depletion of TRDMT1 affects 5-methylcytosine modification of mRNA and inhibits HEK293 cell proliferation and migration Biochem. Biophys. Res. Commun. 2019 520 60 66 10.1016/j.bbrc.2019.09.098 31570165 45. Li J. Li H. Long T. Dong H. Wang E.D. Liu R.J. Archaeal NSUN6 catalyzes m 5 Nucleic Acids Res. 2019 47 2041 2055 10.1093/nar/gky1236 30541086 PMC6393295 46. Squires J.E. Patel H.R. Nousch M. Sibbritt T. Humphreys D.T. Parker B.J. Suter C.M. Preiss T. Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA Nucleic Acids Res. 2012 40 5023 5033 10.1093/nar/gks144 22344696 PMC3367185 47. Gonskikh Y. Tirrito C. Bommisetti P. Mendoza-Figueroa M.S. Stoute J. Kim J. Wang Q. Song Y. Liu K.F. Spatial regulation of NSUN2-mediated tRNA m 5 Nucleic Acids Res. 2025 53 gkae1169 10.1093/nar/gkae1169 39673800 PMC11754655 48. Dominissini D. Rechavi G. 5-methylcytosine mediates nuclear export of mRNA Cell Res. 2017 27 717 719 10.1038/cr.2017.73 28534483 PMC5518879 49. Shinoda S. Kitagawa S. Nakagawa S. Wei F.Y. Tomizawa K. Araki K. Araki M. Suzuki T. Suzuki T. Mammalian NSUN2 introduces 5-methylcytidines into mitochondrial tRNAs Nucleic Acids Res. 2019 47 8734 8745 10.1093/nar/gkz575 31287866 PMC6895283 50. Li P. Ying S. Zou Y. Wang X. Zhang R. Huang C. Dai M. Xu K. Feng G. Li X. NSun2-Mediated tsRNAs Alleviate Liver Fibrosis via FAK Dephosphorylation Cell Prolif. 2025 e70058 10.1111/cpr.70058 40355098 51. Li M. Tao Z. Zhao Y. Li L. Zheng J. Li Z. Chen X. 5-methylcytosine RNA methyltransferases and their potential roles in cancer J. Transl. Med. 2022 20 214 10.1186/s12967-022-03427-2 35562754 PMC9102922 52. Chen Y.S. Yang W.L. Zhao Y.L. Yang Y.G. Dynamic transcriptomic m 5 Wiley Interdiscip. Rev. RNA 2021 12 e1639 10.1002/wrna.1639 33438329 53. Shen Q. Zhang Q. Shi Y. Shi Q. Jiang Y. Gu Y. Li Z. Li X. Zhao K. Wang C. Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation Nature 2018 554 123 127 10.1038/nature25434 29364877 54. Shen H. Ontiveros R.J. Owens M.C. Liu M.Y. Ghanty U. Kohli R.M. Liu K.F. TET-mediated 5-methylcytosine oxidation in tRNA promotes translation J. Biol. Chem. 2021 296 100087 10.1074/jbc.RA120.014226 33199375 PMC7949041 55. Li Y. Xue M. Deng X. Dong L. Nguyen L.X.T. Ren L. Han L. Li C. Xue J. Zhao Z. TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal Cell Stem Cell 2023 30 1072 1090.e1010 10.1016/j.stem.2023.07.001 37541212 PMC11166201 56. Tan L. Shi Y.G. Tet family proteins and 5-hydroxymethylcytosine in development and disease Development 2012 139 1895 1902 10.1242/dev.070771 22569552 PMC3347683 57. Wang X. Jin X.-Y. Cheng L. Recent Advance in the Study on 5-Formylcytosine (f 5 Isr. J. Chem. 2024 64 e202300178 10.1002/ijch.202300178 58. Wang X. Wang M. Dai X. Han X. Zhou Y. Lai W. Zhang L. Yang Y. Chen Y. Wang H. RNA 5-methylcytosine regulates YBX2-dependent liquid-liquid phase separation Fundam. Res. 2022 2 48 55 10.1016/j.fmre.2021.10.008 38933916 PMC11197489 59. Yang H. Wang Y. Xiang Y. Yadav T. Ouyang J. Phoon L. Zhu X. Shi Y. Zou L. Lan L. FMRP promotes transcription-coupled homologous recombination via facilitating TET1-mediated m 5 Proc. Natl. Acad. Sci. USA 2022 119 e2116251119 10.1073/pnas.2116251119 35290126 PMC8944906 60. Zhang Y.Y. Li C.T. Zhou Y.J. Li H. Li J. Xiong Q.P. Zhou W. Huang W. Zhang Q.C. Xiang Y. A cohort of mRNAs undergo high-stoichiometry NSUN6-mediated site-specific m 5 Nat. Commun. 2025 16 6119 10.1038/s41467-025-60873-4 40615396 PMC12227774 61. Yang X. Yang Y. Sun B.F. Chen Y.S. Xu J.W. Lai W.Y. Li A. Wang X. Bhattarai D.P. Xiao W. 5-methylcytosine promotes mRNA export—NSUN2 as the methyltransferase and ALYREF as an m 5 Cell Res. 2017 27 606 625 10.1038/cr.2017.55 28418038 PMC5594206 62. Shi M. Zhang H. Wu X. He Z. Wang L. Yin S. Tian B. Li G. Cheng H. ALYREF mainly binds to the 5′ and the 3′ regions of the mRNA in vivo Nucleic Acids Res. 2017 45 9640 9653 10.1093/nar/gkx597 28934468 PMC5766156 63. Su J. Wu G. Ye Y. Zhang J. Zeng L. Huang X. Zheng Y. Bai R. Zhuang L. Li M. NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization Oncogene 2021 40 5814 5828 10.1038/s41388-021-01978-0 34345012 PMC8484015 64. Ma H.L. Bizet M. Soares Da Costa C. Murisier F. de Bony E.J. Wang M.K. Yoshimi A. Lin K.T. Riching K.M. Wang X. SRSF2 plays an unexpected role as reader of m 5 Mol. Cell 2023 83 4239 4254.e4210 10.1016/j.molcel.2023.11.003 38065062 PMC11090011 65. Song H. Zhang J. Liu B. Xu J. Cai B. Yang H. Straube J. Yu X. Ma T. Biological roles of RNA m 5 Biomark. Res. 2022 10 15 10.1186/s40364-022-00362-8 35365216 PMC8973801 66. Huang T. Chen W. Liu J. Gu N. Zhang R. Genome-wide identification of mRNA 5-methylcytosine in mammals Nat. Struct. Mol. Biol. 2019 26 380 388 10.1038/s41594-019-0218-x 31061524 67. Schumann U. Zhang H.N. Sibbritt T. Pan A. Horvath A. Gross S. Clark S.J. Yang L. Preiss T. Multiple links between 5-methylcytosine content of mRNA and translation BMC Biol. 2020 18 40 10.1186/s12915-020-00769-5 32293435 PMC7158060 68. Liu Y. Yang Y. Wu R. Gao C.C. Liao X. Han X. Zeng B. Huang C. Luo Y. Liu Y. mRNA m 5 5 Cell. Mol. Life Sci. 2022 79 481 10.1007/s00018-022-04474-0 35962235 PMC11072269 69. Chen Y. Zuo X. Wei Q. Xu J. Liu X. Liu S. Wang H. Luo Q. Wang Y. Yang Y. Upregulation of LRRC8A by m 5 Int. J. Biol. Sci. 2023 19 691 704 10.7150/ijbs.79205 36632452 PMC9830503 70. Yang Y. Wang L. Han X. Yang W.L. Zhang M. Ma H.L. Sun B.F. Li A. Xia J. Chen J. RNA 5-Methylcytosine Facilitates the Maternal-to-Zygotic Transition by Preventing Maternal mRNA Decay Mol. Cell 2019 75 1188 1202.e1111 10.1016/j.molcel.2019.06.033 31399345 71. Wang J.Z. Zhu W. Han J. Yang X. Zhou R. Lu H.C. Yu H. Yuan W.B. Li P.C. Tao J. The role of the HIF-1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer Cancer Commun. 2021 41 560 575 10.1002/cac2.12158 PMC8286140 33991457 72. Wang N. Chen R.X. Deng M.H. Wei W.S. Zhou Z.H. Ning K. Li Y.H. Li X.D. Ye Y.L. Wen J.H. m 5 Cell Death Dis. 2023 14 139 10.1038/s41419-023-05661-y 36806253 PMC9938871 73. Navarro-Torné A. Anderson A. Panwar K. Ghys E. Benninghoff B. Weynants V. Beddows S. Checchi M. Corrigendum to How has post-implementation surveillance of high-coverage vaccination with HPV16/18-AS04 vaccine in England added to evidence about its cross-protective effects? Vaccine 2024 42 126215 Erratum in Vaccine 2025 47 10.1016/j.vaccine.2024.126215 39213982 74. Jin Y. Yao J. Fu J. Huang Q. Luo Y. You Y. Zhang W. Zhong Q. Xia T. Xia L. ALYREF promotes the metastasis of nasopharyngeal carcinoma by increasing the stability of NOTCH1 mRNA Cell Death Dis. 2024 15 578 10.1038/s41419-024-06959-1 39117671 PMC11310353 75. Chen Y. Sierzputowska-Gracz H. Guenther R. Everett K. Agris P.F. 5-Methylcytidine is required for cooperative binding of Mg 2+ Biochemistry 1993 32 10249 10253 10.1021/bi00089a047 8399153 76. Yang L. Perrera V. Saplaoura E. Apelt F. Bahin M. Kramdi A. Olas J. Mueller-Roeber B. Sokolowska E. Zhang W. m 5 Curr. Biol. 2019 29 2465 2476.e2465 10.1016/j.cub.2019.06.042 31327714 77. Burgess A.L. David R. Searle I.R. Conservation of tRNA and rRNA 5-methylcytosine in the kingdom Plantae BMC Plant Biol. 2015 15 199 10.1186/s12870-015-0580-8 26268215 PMC4535395 78. Metodiev M.D. Spåhr H. Loguercio Polosa P. Meharg C. Becker C. Altmueller J. Habermann B. Larsson N.G. Ruzzenente B. NSUN4 is a dual function mitochondrial protein required for both methylation of 12S rRNA and coordination of mitoribosomal assembly PLoS Genet. 2014 10 e1004110 10.1371/journal.pgen.1004110 24516400 PMC3916286 79. Amort T. Rieder D. Wille A. Khokhlova-Cubberley D. Riml C. Trixl L. Jia X.Y. Micura R. Lusser A. Distinct 5-methylcytosine profiles in poly(A) RNA from mouse embryonic stem cells and brain Genome Biol. 2017 18 1 10.1186/s13059-016-1139-1 28077169 PMC5225599 80. David R. Burgess A. Parker B. Li J. Pulsford K. Sibbritt T. Preiss T. Searle I.R. Transcriptome-Wide Mapping of RNA 5-Methylcytosine in Arabidopsis mRNAs and Noncoding RNAs Plant Cell 2017 29 445 460 10.1105/tpc.16.00751 28062751 PMC5385953 81. Dubin D.T. Taylor R.H. The methylation state of poly A-containing messenger RNA from cultured hamster cells Nucleic Acids Res. 1975 2 1653 1668 10.1093/nar/2.10.1653 1187339 PMC343535 82. Iwanami Y. Brown G.M. Methylated bases of ribosomal ribonucleic acid from HeLa cells Arch. Biochem. Biophys. 1968 126 8 15 10.1016/0003-9861(68)90553-5 5671075 83. Frommer M. McDonald L.E. Millar D.S. Collis C.M. Watt F. Grigg G.W. Molloy P.L. Paul C.L. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands Proc. Natl. Acad. Sci. USA 1992 89 1827 1831 10.1073/pnas.89.5.1827 1542678 PMC48546 84. Gu W. Hurto R.L. Hopper A.K. Grayhack E.J. Phizicky E.M. Depletion of Saccharomyces cerevisiae tRNA(His) guanylyltransferase Thg1p leads to uncharged tRNAHis with additional m 5 Mol. Cell. Biol. 2005 25 8191 8201 10.1128/MCB.25.18.8191-8201.2005 16135808 PMC1234336 85. Guo G. Pan K. Fang S. Ye L. Tong X. Wang Z. Xue X. Zhang H. Advances in mRNA 5-methylcytosine modifications: Detection, effectors, biological functions, and clinical relevance Mol. Ther. Nucleic Acids 2021 26 575 593 10.1016/j.omtn.2021.08.020 34631286 PMC8479277 86. Zhang L.S. Dai Q. He C. Base-Resolution Sequencing Methods for Whole-Transcriptome Quantification of mRNA Modifications Acc. Chem. Res. 2024 57 47 58 10.1021/acs.accounts.3c00532 38079380 PMC10765377 87. Khoddami V. Cairns B.R. Identification of direct targets and modified bases of RNA cytosine methyltransferases Nat. Biotechnol. 2013 31 458 464 10.1038/nbt.2566 23604283 PMC3791587 88. George H. Ule J. Hussain S. Illustrating the Epitranscriptome at Nucleotide Resolution Using Methylation-iCLIP (miCLIP) Methods Mol. Biol. 2017 1562 91 106 10.1007/978-1-4939-6807-7_7 28349456 89. Zhao L. Zhang H. Kohnen M.V. Prasad K. Gu L. Reddy A.S.N. Analysis of Transcriptome and Epitranscriptome in Plants Using PacBio Iso-Seq and Nanopore-Based Direct RNA Sequencing Front. Genet. 2019 10 253 10.3389/fgene.2019.00253 30949200 PMC6438080 90. Chan S.L. Wong V.W. Qin S. Chan H.L. Infection and Cancer: The Case of Hepatitis B J. Clin. Oncol. 2016 34 83 90 10.1200/JCO.2015.61.5724 26578611 91. Rizzo G.E.M. Cabibbo G. Craxì A. Hepatitis B Virus-Associated Hepatocellular Carcinoma Viruses 2022 14 986 10.3390/v14050986 35632728 PMC9146458 92. D’Souza S. Lau K.C. Coffin C.S. Patel T.R. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma World J. Gastroenterol. 2020 26 5759 5783 10.3748/wjg.v26.i38.5759 33132633 PMC7579760 93. Herrscher C. Roingeard P. Blanchard E. Hepatitis B Virus Entry into Cells Cells 2020 9 1486 10.3390/cells9061486 32570893 PMC7349259 94. Tsukuda S. Watashi K. Hepatitis B virus biology and life cycle Antivir. Res. 2020 182 104925 10.1016/j.antiviral.2020.104925 32866519 95. Pollicino T. Caminiti G. HBV-Integration Studies in the Clinic: Role in the Natural History of Infection Viruses 2021 13 368 10.3390/v13030368 33652619 PMC7996909 96. Mason W.S. Liu C. Aldrich C.E. Litwin S. Yeh M.M. Clonal expansion of normal-appearing human hepatocytes during chronic hepatitis B virus infection J. Virol. 2010 84 8308 8315 10.1128/JVI.00833-10 20519397 PMC2916518 97. Péneau C. Imbeaud S. La Bella T. Hirsch T.Z. Caruso S. Calderaro J. Paradis V. Blanc J.F. Letouzé E. Nault J.C. Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma Gut 2022 71 616 626 10.1136/gutjnl-2020-323153 33563643 PMC8862055 98. Wang J. Zindy F. Chenivesse X. Lamas E. Henglein B. Bréchot C. Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma Oncogene 1992 7 1653 1656 1321406 99. Zoulim F. Chen P.J. Dandri M. Kennedy P.T. Seeger C. Hepatitis B virus DNA integration: Implications for diagnostics, therapy, and outcome J. Hepatol. 2024 81 1087 1099 10.1016/j.jhep.2024.06.037 38971531 100. Hossain M.G. Mahmud M.M. Nazir K.H.M.N.H. Ueda K. PreS1 Mutations Alter the Large HBsAg Antigenicity of a Hepatitis B Virus Strain Isolated in Bangladesh Int. J. Mol. Sci. 2020 21 546 10.3390/ijms21020546 31952213 PMC7014173 101. Chevaliez S. Rodriguez C. Poiteau L. Soulier A. Donati F. Darty-Mercier M. Pioche C. Leroy V. Brodard V. Zoulim F. Primary resistance of hepatitis B virus to nucleoside and nucleotide analogues J. Viral Hepat. 2019 26 278 286 10.1111/jvh.13025 30339311 102. Podlaha O. Gane E. Brunetto M. Fung S. Chuang W.L. Pan C.Q. Jiang Z. Liu Y. Bhardwaj N. Mukherjee P. Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patients Sci. Rep. 2019 9 10529 10.1038/s41598-019-46609-7 31324819 PMC6642195 103. Lin Y.-T. Jeng L.-B. Chan W.-L. Su I.-J. Teng C.-F. Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins: Clinical and Molecular Implications in Hepatocellular Carcinoma Viruses 2021 13 862 10.3390/v13050862 34066744 PMC8151789 104. Panasiuk Y.V. Vlasenko N.V. Churilova N.S. Klushkina V.V. Dubodelov D.V. Kudryavtseva E.N. Korabelnikova M.I. Rodionova Z.S. Semenenko T.A. Kuzin S.N. Modern views on the role of X Hepadnaviridae: Orthohepadnavirus: Hepatitis B virus Probl. Virol. 2022 67 7 17 10.36233/0507-4088-84 35293184 105. Ren F. Li W. Xiang A. Wang L. Li M. Guo Y. Distribution and difference of APOBEC-induced mutations in the TpCpW context of HBV DNA between HCC and non-HCC J. Med. Virol. 2020 92 53 61 10.1002/jmv.25572 31429946 106. Yan W. Rao D. Fan F. Liang H. Zhang Z. Dong H. Hepatitis B virus X protein and TGF-β: Partners in the carcinogenic journey of hepatocellular carcinoma Front. Oncol. 2024 14 1407434 10.3389/fonc.2024.1407434 38962270 PMC11220127 107. Salerno D. Chiodo L. Alfano V. Floriot O. Cottone G. Paturel A. Pallocca M. Plissonnier M.L. Jeddari S. Belloni L. Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription Gut 2020 69 2016 2024 10.1136/gutjnl-2019-319637 32114505 PMC7569396 108. An P. Xu J. Yu Y. Winkler C.A. Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma Front. Genet. 2018 9 261 10.3389/fgene.2018.00261 30073017 PMC6060371 109. Heukers R. Altintas I. Raghoenath S. De Zan E. Pepermans R. Roovers R.C. Haselberg R. Hennink W.E. Schiffelers R.M. Kok R.J. Targeting hepatocyte growth factor receptor (Met) positive tumor cells using internalizing nanobody-decorated albumin nanoparticles Biomaterials 2014 35 601 610 10.1016/j.biomaterials.2013.10.001 24139763 110. Grohmann M. Wiede F. Dodd G.T. Gurzov E.N. Ooi G.J. Butt T. Rasmiena A.A. Kaur S. Gulati T. Goh P.K. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC Cell 2018 175 1289 1306.e1220 10.1016/j.cell.2018.09.053 30454647 PMC6242467 111. Zhou S.J. Deng Y.L. Liang H.F. Jaoude J.C. Liu F.Y. Hepatitis B virus X protein promotes CREB-mediated activation of miR-3188 and Notch signaling in hepatocellular carcinoma Cell Death Differ. 2017 24 1577 1587 10.1038/cdd.2017.87 28574502 PMC5563993 112. Tu W. Gong J. Tian D. Wang Z. Hepatitis B Virus X Protein Induces SATB1 Expression Through Activation of ERK and p38MAPK Pathways to Suppress Anoikis Dig. Dis. Sci. 2019 64 3203 3214 10.1007/s10620-019-05681-9 31147803 113. Yang W.Y. Rao P.S. Luo Y.C. Lin H.K. Huang S.H. Yang J.M. Yuh C.H. Omics-based Investigation of Diet-induced Obesity Synergized with HBx, Src, and p53 Mutation Accelerating Hepatocarcinogenesis in Zebrafish Model Cancers 2019 11 1899 10.3390/cancers11121899 31795276 PMC6966430 114. Wei X. Xiang T. Ren G. Tan C. Liu R. Xu X. Wu Z. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A Cell Signal. 2013 25 439 446 10.1016/j.cellsig.2012.10.013 23124077 115. Ji L. Lin Z. Wan Z. Xia S. Jiang S. Cen D. Cai L. Xu J. Cai X. miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR Cell Death Dis. 2020 11 250 10.1038/s41419-020-2413-4 32313144 PMC7170966 116. Imam H. Kim G.W. Mir S.A. Khan M. Siddiqui A. Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts PLoS Pathog. 2020 16 e1008338 10.1371/journal.ppat.1008338 32059034 PMC7046284 117. Kim G.W. Siddiqui A. Hepatitis B Virus X Protein Expression Is Tightly Regulated by N6-Methyladenosine Modification of Its mRNA J. Virol. 2022 96 e0165521 10.1128/jvi.01655-21 34851655 PMC8865537 118. Kim G.W. Imam H. Khan M. Siddiqui A. N 6 J. Biol. Chem. 2020 295 13123 13133 10.1074/jbc.RA120.014260 32719095 PMC7489896 119. Feng J. Xu T. He M. Li J. Yao P. Ma C. Yang S. Xu Z. Yan K. Chen X. NSUN2-mediated m 5 PLoS Pathog. 2023 19 e1011808 10.1371/journal.ppat.1011808 38048324 PMC10721180 120. Su P.A. Chang C.H. Yen S.B. Wu H.Y. Tung W.J. Hu Y.P. Chen Y.I. Lin M.H. Shih C. Chen P.J. Epitranscriptomic cytidine methylation of the hepatitis B viral RNA is essential for viral reverse transcription and particle production Proc. Natl. Acad. Sci. USA 2024 121 e2400378121 10.1073/pnas.2400378121 38830096 PMC11181118 121. Sato S. Li K. Kameyama T. Hayashi T. Ishida Y. Murakami S. Watanabe T. Iijima S. Sakurai Y. Watashi K. The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus Immunity 2015 42 123 132 10.1016/j.immuni.2014.12.016 25557055 122. Ding S. Liu H. Liu L. Ma L. Chen Z. Zhu M. Liu L. Zhang X. Hao H. Zuo L. Epigenetic addition of m 5 Cell Death Dis. 2024 15 39 10.1038/s41419-023-06412-9 38216565 PMC10786922 123. Zhang Q. Zhu B. Yang H. Li F. Qu Y. Lu L. Zhang Q. Exploration of YBX1 role in the prognostic value and immune characteristics by single-cell and bulk sequencing analysis for liver hepatocellular carcinoma J. Gene Med. 2024 26 e3680 10.1002/jgm.3680 38448368 124. Zhang Q. Zheng Q. Yu X. He Y. Guo W. Overview of distinct 5-methylcytosine profiles of messenger RNA in human hepatocellular carcinoma and paired adjacent non-tumor tissues J. Transl. Med. 2020 18 245 10.1186/s12967-020-02417-6 32571340 PMC7310161 125. Xue C. Gu X. Zheng Q. Shi Q. Yuan X. Su Y. Jia J. Jiang J. Lu J. Li L. ALYREF mediates RNA m 5 Signal Transduct. Target. Ther. 2023 8 130 10.1038/s41392-023-01395-7 36934090 PMC10024699 126. Nulali J. Zhang K. Long M. Wan Y. Liu Y. Zhang Q. Yang L. Hao J. Yang L. Song H. ALYREF-mediated RNA 5-Methylcytosine modification Promotes Hepatocellular Carcinoma Progression Via Stabilizing EGFR mRNA and pSTAT3 activation Int. J. Biol. Sci. 2024 20 331 346 10.7150/ijbs.82316 38164181 PMC10750289 127. Sun Z. Xue S. Zhang M. Xu H. Hu X. Chen S. Liu Y. Guo M. Cui H. Aberrant NSUN2-mediated m 5 Oncogene 2020 39 6906 6919 10.1038/s41388-020-01475-w 32978516 PMC7644462 128. Li B. Li F. Gu T. Guo Y. Shen B. Xu X. Shen Z. Chen L. Zhang Q. Dong H. Specific knockdown of Y-box binding protein 1 in hepatic progenitor cells inhibits proliferation and alleviates liver fibrosis Eur. J. Pharmacol. 2022 921 174866 10.1016/j.ejphar.2022.174866 35231468 129. Li Q. Pan Y. Zhang J. Hu B. Qin D. Liu S. Chen N. Zhang L. TET2 regulation of alcoholic fatty liver via Srebp1 mRNA in paraspeckles iScience 2024 27 109278 10.1016/j.isci.2024.109278 38482502 PMC10933471 130. Liu Y. Zhao Y. Wu R. Chen Y. Chen W. Liu Y. Luo Y. Huang C. Zeng B. Liao X. mRNA m 5 RNA Biol. 2021 18 711 721 10.1080/15476286.2021.1980694 34570675 PMC8782175 131. Zhang H. Zhai X. Liu Y. Xia Z. Xia T. Du G. Zhou H. Franziska Strohmer D. Bazhin A.V. Li Z. NOP2-mediated m 5 Research 2023 6 0184 10.34133/research.0184 37398932 PMC10313139 132. Qu S. Jin L. Huang H. Lin J. Gao W. Zeng Z. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis BMC Cancer 2021 21 686 10.1186/s12885-021-08449-5 34112124 PMC8194239 133. Kim G.W. Imam H. Khan M. Mir S.A. Kim S.J. Yoon S.K. Hur W. Siddiqui A. HBV-Induced Increased N6 Methyladenosine Modification of PTEN RNA Affects Innate Immunity and Contributes to HCC Hepatology 2021 73 533 547 10.1002/hep.31313 32394474 PMC7655655 134. Kim G.W. Moon J.S. Gudima S.O. Siddiqui A. N 6 J. Virol. 2022 96 e0112422 10.1128/jvi.01124-22 36102650 PMC9555152 135. Wei T. Li J. Lei X. Lin R. Wu Q. Zhang Z. Shuai S. Tian R. Multimodal CRISPR screens uncover DDX39B as a global repressor of A-to-I RNA editing Cell Rep. 2025 44 116009 10.1016/j.celrep.2025.116009 40652511 136. Courtney D.G. Tsai K. Bogerd H.P. Kennedy E.M. Law B.A. Emery A. Swanstrom R. Holley C.L. Cullen B.R. Epitranscriptomic Addition of m 5 Cell Host Microbe 2019 26 217 227 10.1016/j.chom.2019.07.005 31415754 PMC6714563 137. Wang H. Feng J. Fu Z. Xu T. Liu J. Yang S. Li Y. Deng J. Zhang Y. Guo M. Epitranscriptomic m 5 Sci. Adv. 2024 10 eadn9519 10.1126/sciadv.adn9519 39110796 PMC11305390 138. Courtney D.G. Chalem A. Bogerd H.P. Law B.A. Kennedy E.M. Holley C.L. Cullen B.R. Extensive Epitranscriptomic Methylation of A and C Residues on Murine Leukemia Virus Transcripts Enhances Viral Gene Expression mBio 2019 10 e01209 e01219 10.1128/mBio.01209-19 31186331 PMC6561033 139. Li Z.L. Xie Y. Xie Y. Chen H. Zhou X. Liu M. Zhang X.L. HCV 5-Methylcytosine Enhances Viral RNA Replication through Interaction with m 5 ACS Chem. Biol. 2024 19 1648 1660 10.1021/acschembio.4c00322 38954741 140. Wang H. Feng J. Zeng C. Liu J. Fu Z. Wang D. Wang Y. Zhang L. Li J. Jiang A. NSUN2-mediated M 5 Emerg. Microbes Infect. 2023 12 2178238 10.1080/22221751.2023.2178238 36748584 PMC9946332 141. Li Z.L. Xie Y. Wang Y. Wang J. Zhou X. Zhang X.L. NSUN2-mediated HCV RNA m 5 Genom. Proteom. Bioinform. 2025 23 qzaf008 10.1093/gpbjnl/qzaf008 PMC12233092 39957240 142. Courtney D.G. Post-Transcriptional Regulation of Viral RNA through Epitranscriptional Modification Cells 2021 10 1129 10.3390/cells10051129 34066974 PMC8151693 143. Henry B.A. Kanarek J.P. Kotter A. Helm M. Lee N. 5-methylcytosine modification of an Epstein-Barr virus noncoding RNA decreases its stability RNA 2020 26 1038 1048 10.1261/rna.075275.120 32354721 PMC7373997 144. Song D. An K. Zhai W. Feng L. Xu Y. Sun R. Wang Y. Yang Y.G. Kan Q. Tian X. NSUN2-mediated mRNA m 5 Genom. Proteom. Bioinform. 2023 21 823 833 10.1016/j.gpb.2022.09.007 36183976 PMC10787115 Figure 1 Writer, eraser, and reader proteins of RNA m 5 5 5 5 Figure 2 Biological function of m 5 A 5 B 5 Figure 3 Detection methods of RNA m 5 5 A B C D E F Figure 4 Mechanisms of HBV-induced HCC formation. The molecular mechanisms of HBV-related HCC mainly include four aspects: HBV DNA integrates into the host genome, the rapid turnover of hepatocytes and increased inflammation caused by the host immune response, HBV genomic mutations, and abnormal expressions of HBx. Figure 5 The role of m 5 5 5 viruses-17-01159-t001_Table 1 Table 1 Summary of major RNA modifications in viral infections. Modifications RNA Substrates Typical Location Key Roles in Viral Infections References m 5 mRNA, tRNA, rRNA, viral RNA CDS/UTR RNA stability, translation efficiency, immune evasion, nuclear export, and splicing [ 10 11 12 13 14 m 6 mRNA, lncRNA, circRNA, rRNA, viral RNA 3′ UTR, near stop codon RNA stability, translation efficiency, immune evasion, nuclear export, splicing, and secondary structure [ 15 16 17 18 19 ac4C mRNA, tRNA, rRNA, viral RNA Coding region RNA stability, translation efficiency, splicing, and secondary structure [ 15 20 21 22 23 24 25 Ψ tRNA, rRNA, viral RNA Structural regions RNA stability, translation efficiency, and pre-mRNA processing [ 26 27 28 29 m 1 mRNA, tRNA, viral RNA 5′ UTR and coding regions RNA stability and splicing [ 22 23 30 m 7 mRNA, rRNA, viral RNA 5′ cap, internal sites RNA stability, translation efficiency, and ribosome biogenesis [ 31 32 33 34 Nm rRNA, snRNA, mRNA, viral RNA Ribose 2′-hydroxyl RNA stability, translation efficiency, and pre-mRNA processing [ 35 36 37 viruses-17-01159-t002_Table 2 Table 2 m 5 Virus Writer Notable m 5 Key Functions References HIV-1 NSUN2 Gag-pol overlap, splice sites Export, translation, splicing regulation [ 136 142 HCV NSUN2 C7525 (NS5A) RNA stability, replication, release [ 141 EV71 NSUN2 5′ UTR nt 584, CDS nt 1460 IRES-mediated translation, RNA stability [ 11 SARS-CoV-2 NSUN2 3′ UTR, ORF dynamics RNA turnover, replication regulation [ 140 EBV NSUN2 EBER1 C145 ncRNA stability modulation [ 143 MLV NSUN2 5′ UTR, 3′ UTR Genome packaging, RNA stability, immune evasion [ 138 ",
  "metadata": {
    "Title of this paper": "NSUN2-mediated mRNA m",
    "Journal it was published in:": "Viruses",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12474464/"
  }
}